Explore
Search CRO profiles and published service listings independently.
Type at least 2 characters to search.
View all results →At Catalent, we screen formulation and bioavailability-enabling approaches against the molecule’s developability risks.
We define the engagement around solubility, dissolution, permeability, solid state, API availability, target dose, route, modeling, and candidate technologies.
Sponsors can expect comparative screening data, prototypes, development rationale, and a recommended path toward clinical supply.
This offering is intended for poorly soluble small molecules moving from late discovery toward formulation selection and Phase I.
Editorial note: Scope, availability, geography, and regulatory applicability should be confirmed directly with the provider. Official source reviewed: https://www.catalent.com/pharma/small-molecule/development/bioavailability-enhancement
ONE PLATFORM. THREE WAYS TO MOVE FORWARD.
CROaccess helps life science teams move from an open-ended search to a confident partner decision. Choose the level of support that fits your program and your team.
Search CRO profiles and published service listings independently.
Describe your program and receive recommendations aligned with services, stage, and location.
Get hands-on support through outreach, comparison, proposal review, and CRO selection.